Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $329.82)
- $329.82 P/E (TTM): 23.18X Cap: $177.99B
- View AMGN Profile
- View Questions on AMGN
-
Cerner Corporation (CERN)
- P/E (TTM): 46.72X
- View CERN Profile
- View Questions on CERN
-
AbbVie Inc. (ABBV $206.60)
- $206.60 P/E (TTM): 87.54X Cap: $365.42B
- View ABBV Profile
- View Questions on ABBV
-
Merck & Company Inc. (MRK $112.16)
- $112.16 P/E (TTM): 15.41X Cap: $277.17B
- View MRK Profile
- View Questions on MRK
-
Pfizer Inc. (PFE $26.33)
- $26.33 P/E (TTM): 19.36X Cap: $149.77B
- View PFE Profile
- View Questions on PFE
-
Teladoc Health Inc. (TDOC $6.46)
- $6.46 Cap: $1.16B
- View TDOC Profile
- View Questions on TDOC
-
WELL Health Technologies Corp. (WELL $4.27)
- $4.27 Cap: $1.09B
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
-
Change Healthcare Inc. (CHNG)
Q: In your response to Marco's question on March 11 you mentioned you felt there were better opportunities in the US. Could you mention your top choices. Thank you.
-
Change Healthcare Inc. (CHNG)
-
Health Catalyst Inc (HCAT $1.45)
- $1.45 Cap: $106M
- View HCAT Profile
- View Questions on HCAT
Q: Hello there,
Any views on CHNG ? Good for a growth portfolio ? Anything better in that sector ?
Reply at your leisure. No rush.
Season's greetings to all of you,
Jacques IDS
Any views on CHNG ? Good for a growth portfolio ? Anything better in that sector ?
Reply at your leisure. No rush.
Season's greetings to all of you,
Jacques IDS
Insiders
Share Information
SEC Filings
News and Media